SCHEMBL764280

SCHEMBL764280

O=C(c1ccc(-c2cccs2)cc1F)N1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 4/20 0.53
BCR P11274 4/20 0.53
HDAC3 O15379 4/20 0.53
HDAC1 Q13547 4/20 0.53
HDAC2 Q92769 4/20 0.53
HPGD P15428 3/20 0.52
NPC1 O15118 1/20 0.52
ALDH1A1 P00352 1/20 0.52
TP53 P04637 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
CPS1 P31327 1/20 0.46
CNR1 P21554 1/20 0.44
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL764268 0.99 ABL1 (0.54) ABL1BCRHDAC3HDAC1HDAC2
SCHEMBL3901121 0.85 HDAC3 (0.62) ABL1BCRHDAC3HDAC1HDAC2
SCHEMBL3901114 0.84 HDAC3 (0.55) ABL1BCRHDAC3HDAC1HDAC2
SCHEMBL764282 0.83 HDAC3 (0.52) ABL1BCRHDAC3HDAC1HDAC2
SCHEMBL10331348 0.79 YEATS4 (0.53) HPGDALDH1A1CPS1CNR1KCNH2
SCHEMBL4652841 0.78 PTPN1 (0.51) HDAC3HDAC1HDAC2KDM4EKCNH2
SCHEMBL10331353 0.78 YEATS4 (0.54) HPGDALDH1A1KDM4ECPS1CNR1
SCHEMBL3197916 0.77 HRH3 (0.48) HDAC3HDAC1HDAC2KCNH2HRH3
SCHEMBL3197908 0.77 HRH3 (0.48) HDAC3HDAC1HDAC2KCNH2HRH3
SCHEMBL764236 0.76 ABL1 (0.76) ABL1BCRHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed
WO-2008057859-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-I AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed